The latest price target for Ambev (NYSE:ABEV) was reported by UBS on July 31, 2024. The analyst firm set a price target for $2.90 expecting ABEV to rise to within 12 months (a possible 25.54% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Ambev (NYSE:ABEV) was provided by UBS, and Ambev maintained their buy rating.

The last upgrade for Ambev SA happened on July 13, 2022 when JP Morgan raised their price target to N/A. JP Morgan previously had a neutral for Ambev SA.

The last downgrade for Ambev SA happened on March 4, 2024 when Barclays changed their price target from $3.5 to $3 for Ambev SA.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ambev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ambev was filed on July 31, 2024 so you should expect the next rating to be made available sometime around July 31, 2025.

While ratings are subjective and will change, the latest Ambev (ABEV) rating was a maintained with a price target of $3.20 to $2.90. The current price Ambev (ABEV) is trading at is $2.31, which is out of the analyst’s predicted range.